Literature DB >> 15489954

Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Virginie Pétrilli1, Zdenko Herceg, Paul O Hassa, Nimesh S A Patel, Rosanna Di Paola, Ulrich Cortes, Laura Dugo, Helder-Mota Filipe, Christoph Thiemermann, Michael O Hottiger, Salvatore Cuzzocrea, Zhao-Qi Wang.   

Abstract

Poly(ADP-ribosyl)ation is rapidly formed in cells following DNA damage and is regulated by poly(ADP-ribose) polymerase-1 (PARP-1). PARP-1 is known to be involved in various cellular processes, such as DNA repair, genomic stability, transcription, and cell death. During apoptosis, PARP-1 is cleaved by caspases to generate 89-kDa and 24-kDa fragments, a hallmark of apoptosis. This cleavage is thought to be a regulatory event for cellular death. In order to understand the biological significance of PARP-1 cleavage, we generated a PARP-1 knockin (PARP-1(KI/KI)) mouse model, in which the caspase cleavage site of PARP-1, DEVD(214), was mutated to render the protein resistant to caspases during apoptosis. While PARP-1(KI/KI) mice developed normally, they were highly resistant to endotoxic shock and to intestinal and renal ischemia-reperfusions, which were associated with reduced inflammatory responses in the target tissues and cells due to the compromised production of specific inflammatory mediators. Despite normal binding of NF-kappaB to DNA, NF-kappaB-mediated transcription activity was impaired in the presence of caspase-resistant PARP-1. This study provides a novel insight into the function of PARP-1 in inflammation and ischemia-related pathophysiologies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489954      PMCID: PMC522248          DOI: 10.1172/JCI21854

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Differential effect of caspase inhibition on proinflammatory cytokine release in septic patients.

Authors:  A Oberholzer; L Härter; A Feilner; U Steckholzer; O Trentz; W Ertel
Journal:  Shock       Date:  2000-09       Impact factor: 3.454

2.  Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis.

Authors:  R Nevière; H Fauvel; C Chopin; P Formstecher; P Marchetti
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

3.  Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice.

Authors:  S Kühnle; P Nicotera; A Wendel; M Leist
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

4.  Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.

Authors:  M Masutani; H Suzuki; N Kamada; M Watanabe; O Ueda; T Nozaki; K Jishage; T Watanabe; T Sugimoto; H Nakagama; T Ochiya; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.

Authors:  M Endres; S Namura; M Shimizu-Sasamata; C Waeber; L Zhang; T Gómez-Isla; B T Hyman; M A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  1998-03       Impact factor: 6.200

6.  Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats.

Authors:  D R Martin; A J Lewington; M R Hammerman; B J Padanilam
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-11       Impact factor: 3.619

7.  Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption.

Authors:  A A Pieper; T Walles; G Wei; E E Clements; A Verma; S H Snyder; J L Zweier
Journal:  Mol Med       Date:  2000-04       Impact factor: 6.354

8.  Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase.

Authors:  M Kameoka; K Ota; T Tetsuka; Y Tanaka; A Itaya; T Okamoto; K Yoshihara
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

9.  Irreversible binding of poly(ADP)ribose polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis.

Authors:  M E Smulson; D Pang; M Jung; A Dimtchev; S Chasovskikh; A Spoonde; C Simbulan-Rosenthal; D Rosenthal; A Yakovlev; A Dritschilo
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

10.  Lung fibroblasts undergo apoptosis following alveolarization.

Authors:  M C Bruce; C E Honaker; R J Cross
Journal:  Am J Respir Cell Mol Biol       Date:  1999-02       Impact factor: 6.914

View more
  38 in total

1.  Mitogen-activated protein kinase-activated protein kinase 2 mediates apoptosis during lung vascular permeability by regulating movement of cleaved caspase 3.

Authors:  Mahendra Damarla; Ahmad R Parniani; Laura Johnston; Hasina Maredia; Leonid Serebreni; Omar Hamdan; Venkataramana K Sidhaye; Larissa A Shimoda; Allen C Myers; Michael T Crow; Eric P Schmidt; Carolyn E Machamer; Matthias Gaestel; Madhavi J Rane; Todd M Kolb; Bo S Kim; Rachel L Damico; Paul M Hassoun
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

2.  High-fat diet feeding causes rapid, non-apoptotic cleavage of caspase-3 in astrocytes.

Authors:  Stephan J Guyenet; Hong T Nguyen; Bang H Hwang; Michael W Schwartz; Denis G Baskin; Joshua P Thaler
Journal:  Brain Res       Date:  2013-03-30       Impact factor: 3.252

3.  Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling.

Authors:  Paola Castri; Yang-Ja Lee; Todd Ponzio; Dragan Maric; Maria Spatz; Joliet Bembry; John Hallenbeck
Journal:  Biochim Biophys Acta       Date:  2014-03

4.  Thioredoxin-interacting protein mediates nuclear-to-plasma membrane communication: role in vascular endothelial growth factor 2 signaling.

Authors:  Oded N Spindel; Chen Yan; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-16       Impact factor: 8.311

Review 5.  Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.

Authors:  David C Hess; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2010-07       Impact factor: 4.705

Review 6.  Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells.

Authors:  Yan Zhang; Ha-Jeong Kim; Soichiro Yamamoto; Xiaoyan Kang; Xiaojing Ma
Journal:  J Interferon Cytokine Res       Date:  2010-03       Impact factor: 2.607

7.  The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells.

Authors:  Xiaoyan Kang; Ha-Jeong Kim; Michelle Ramirez; Sarah Salameh; Xiaojing Ma
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

8.  MicroRNA-489 Induction by Hypoxia-Inducible Factor-1 Protects against Ischemic Kidney Injury.

Authors:  Qingqing Wei; Yong Liu; Pengyuan Liu; Jielu Hao; Mingyu Liang; Qing-Sheng Mi; Jian-Kang Chen; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2016-03-14       Impact factor: 10.121

Review 9.  Sepsis: links between pathogen sensing and organ damage.

Authors:  Elliott Crouser; Matthew Exline; Daren Knoell; Mark D Wewers
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy.

Authors:  Jiyong Liang; Lulu Wang; Chao Wang; Jianfeng Shen; Bojin Su; Anantha L Marisetty; Dexing Fang; Cynthia Kassab; Kang Jin Jeong; Wei Zhao; Yiling Lu; Abhinav K Jain; Zhicheng Zhou; Han Liang; Shao-Cong Sun; Changming Lu; Zhi-Xiang Xu; Qinghua Yu; Shan Shao; XiaoHua Chen; Meng Gao; Francois X Claret; Zhiyong Ding; Jian Chen; Pingsheng Chen; Michelle C Barton; Guang Peng; Gordon B Mills; Amy B Heimberger
Journal:  Cancer Immunol Res       Date:  2020-04-07       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.